{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T14:10:10Z","timestamp":1752243010036,"version":"3.41.2"},"reference-count":45,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"published-print":{"date-parts":[[2025,6,27]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p> The impact of the COVID-19 pandemic on antimicrobial use in Canadian hospitals is not well characterized. We explored the relationship between the COVID-19 pandemic and Canadian hospital antimicrobial purchasing (AMP)\u2014a proxy for consumption. <\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p> Hospital-level AMP data were obtained from IQVIA, a health analytics company, and matched with inpatient patient-day denominator data from 28 hospitals participating in the Canadian Nosocomial Infection Surveillance Program. Monthly AMP was measured using defined daily doses (DDDs) per 1,000 patient-days. Segmented linear regression with hospital-level clustering assessed for step and slope changes in AMP between pre-pandemic (January 1, 2018 \u2013 February 29, 2020) and pandemic (March 1, 2020 \u2013 December 31, 2021) periods. <\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p> Although we found an initial increase in AMP with the onset of the pandemic (+42 DDDs\/1,000 patient-days [pd]) followed by a decreasing trend in AMP during the pandemic (\u22125 DDDs\/1,000 pd per month), neither was statistically significant. Changes in trends varied across antimicrobial classes\/subclasses, with decreases in broad-spectrum penicillins (\u22122 DDDs\/1,000 pd per month, p &lt; .001) and macrolides\/lincosamides (\u22122 DDDs\/1,000 pd per month, p &lt; .001) and an increase in carbapenems (1 DDD\/1,000 pd per month, p &lt; .001). These results coincided with decreases in piperacillin\/tazobactam ( p = .003) and azithromycin ( p = .001) and an increase in meropenem ( p &lt; .001). <\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p> We observed a transient increase in overall AMP with the onset of the pandemic (March 2020) in this exploratory analysis of a sample of 28 hospitals. Changes in trends varied by antimicrobial class\/subclass and individual agent. Further work is needed to discern contributors to these trends, such as changes in inpatient characteristics and treatment guidelines. <\/jats:p><\/jats:sec>","DOI":"10.3138\/jammi-2024-0017","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T10:45:50Z","timestamp":1748515550000},"page":"146-159","source":"Crossref","is-referenced-by-count":0,"title":["Impact of the COVID-19 pandemic on hospital antimicrobial purchasing in Canada (2018\u20132021): An exploratory analysis"],"prefix":"10.3138","volume":"10","author":[{"given":"Janine","family":"Xu","sequence":"first","affiliation":[{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica J","family":"Bartoszko","sequence":"additional","affiliation":[{"name":"Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00eblle","family":"Cayen","sequence":"additional","affiliation":[{"name":"Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenys","family":"Smith","sequence":"additional","affiliation":[{"name":"Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Conly","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cumming School of Medicine, University of Calgary and Alberta Health Services, Calgary, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Frenette","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine and Health Sciences, McGill University, Montr\u00e9al, QC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Happe","sequence":"additional","affiliation":[{"name":"Infection Prevention and Control Canada, Calgary, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B Lynn","family":"Johnston","sequence":"additional","affiliation":[{"name":"Nova Scotia Health Authority, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Longtin","sequence":"additional","affiliation":[{"name":"Jewish General Hospital, Montr\u00e9al, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Mertz","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Pelude","sequence":"additional","affiliation":[{"name":"Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn N","family":"Suh","sequence":"additional","affiliation":[{"name":"Infection Prevention and Control, The Ottawa Hospital, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel JG","family":"Thirion","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wallis","family":"Rudnick","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Antimicrobial Use Working Group and VRI Working Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1696","reference":[{"issue":"2","key":"r1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/jac\/dkw454","volume":"72","author":"Tan C","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"r2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cmi.2020.12.018","volume":"27","author":"Langford BJ","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"r3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13756-022-01085-z","volume":"11","author":"Kariyawasam RM","year":"2022","journal-title":"Antimicrob Resist Infect Control"},{"issue":"12","key":"r4","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","volume":"26","author":"Langford BJ","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"r5","doi-asserted-by":"crossref","first-page":"813213","DOI":"10.3389\/fphar.2022.813213","volume":"13","author":"Yang Y","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1","key":"r6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13756-021-00898-8","volume":"10","author":"Ng TM","year":"2021","journal-title":"Antimicrob Resist Infect Control"},{"issue":"46","key":"r7","doi-asserted-by":"crossref","first-page":"2101020","DOI":"10.2807\/1560-7917.ES.2021.26.46.2101020","volume":"26","author":"H\u00f6gberg LD","year":"2021","journal-title":"Eurosurveillance"},{"issue":"6","key":"r8","doi-asserted-by":"crossref","first-page":"ofab236","DOI":"10.1093\/ofid\/ofab236","volume":"8","author":"Rose AN","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"r9","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmi.2021.10.013","volume":"28","author":"Knight BD","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"r10","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/jac\/dkv373","volume":"71","author":"Tan C","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"r11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13756-020-0684-2","volume":"9","author":"Rudnick W","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"r12","first-page":"348","volume":"46","author":"Bernal JL","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"3","key":"r13","first-page":"7","volume":"2","author":"Zeileis A","year":"2002","journal-title":"R News"},{"issue":"1","key":"r14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/tropicalmed8010023","volume":"8","author":"Foxlee ND","year":"2022","journal-title":"Trop Med Infect Dis"},{"issue":"1","key":"r15","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1017\/ash.2022.268","volume":"2","author":"Elligsen M","year":"2022","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"6","key":"r16","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3390\/antibiotics11060826","volume":"11","author":"Meschiari M","year":"2022","journal-title":"Antibiotics"},{"issue":"6","key":"r17","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3390\/antibiotics11060792","volume":"11","author":"Friedli O","year":"2022","journal-title":"Antibiotics"},{"issue":"1","key":"r18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13756-022-01206-8","volume":"11","author":"Wang T","year":"2022","journal-title":"Antimicrob Resist Infect Control."},{"issue":"2","key":"r19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/antibiotics10020132","volume":"10","author":"Grau S","year":"2021","journal-title":"Antibiotics"},{"key":"r20","doi-asserted-by":"publisher","DOI":"10.3138\/jammi-2020-0041"},{"key":"r21","doi-asserted-by":"crossref","first-page":"vi17","DOI":"10.1093\/jac\/dky115","volume":"73","author":"Zanichelli V","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"r22","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1016\/S2666-5247(21)00039-2","volume":"2","author":"Afshinnekoo E","year":"2021","journal-title":"Lancet Microbe"},{"volume-title":"Clinical practice guideline summary: recommended drugs and biologics in adult patients with COVID-19. Version 1.0","year":"2021","author":"Ontario COVID-19 Science Advisory Table","key":"r23"},{"volume-title":"4000 cancers non diagnostiqu\u00e9s. Le Journal de Quebec","year":"2021","author":"Duchaine H","key":"r24"},{"key":"r25","doi-asserted-by":"crossref","first-page":"671833","DOI":"10.3389\/fpubh.2021.671833","volume":"9","author":"Alami H","year":"2021","journal-title":"Front Public Health"},{"key":"r26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jhin.2022.08.005","volume":"129","author":"Hashad N","year":"2022","journal-title":"J Hosp Infect"},{"issue":"11","key":"r27","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.3390\/antibiotics11111600","volume":"11","author":"Khan S","year":"2022","journal-title":"Antibiotics"},{"issue":"3","key":"r28","doi-asserted-by":"crossref","first-page":"S307","DOI":"10.3138\/cpp.2020-107","volume":"46","author":"Gaudette \u00c9","year":"2020","journal-title":"Can Public Policy"},{"volume-title":"Sales of antibiotics and occurrence of antibiotic resistance in Sweden","year":"2020","author":"Public Health Agency of Sweden and National Veterinary Institute","key":"r29"},{"issue":"6","key":"r30","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/infdis\/jiab208","volume":"224","author":"Ryu S","year":"2021","journal-title":"J Infect Dis"},{"volume-title":"Drug shortage report for piperacillin and tazobactam for injection","year":"2020","key":"r31"},{"issue":"2","key":"r32","doi-asserted-by":"crossref","first-page":"e2163","DOI":"10.1002\/rmv.2163","volume":"31","author":"Oliver ME","year":"2021","journal-title":"Rev Med Virol"},{"issue":"7","key":"r33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.repc.2022.04.005","volume":"41","author":"Laranjo SM","year":"2022","journal-title":"Rev Port Cardiol"},{"issue":"6","key":"r34","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.2021.11517","volume":"326","author":"Oldenburg CE","year":"2021","journal-title":"J Am Med Assoc"},{"issue":"4","key":"r35","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/1715163520929387","volume":"153","author":"Elbeddini A","year":"2020","journal-title":"Can Pharm J"},{"volume-title":"Drug shortages amid the COVID-19 pandemic. US Pharmacist","year":"2021","author":"Bookwalter CM","key":"r36"},{"issue":"4","key":"r37","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3390\/antibiotics11040535","volume":"11","author":"Jeon K","year":"2022","journal-title":"Antibiotics"},{"issue":"4","key":"r38","doi-asserted-by":"crossref","first-page":"106324","DOI":"10.1016\/j.ijantimicag.2021.106324","volume":"57","author":"Lai CC","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"r39","first-page":"1","volume":"51","author":"AlBahrani S","year":"2022","journal-title":"Infection"},{"issue":"1","key":"r40","doi-asserted-by":"crossref","first-page":"S305","DOI":"10.1093\/ofid\/ofab466.609","volume":"8","author":"Lora AJM","year":"2021","journal-title":"Open Forum Infect Dis"},{"volume-title":"COVID-19\u2019s impact on hospital services","year":"2022","author":"Canadian Institute for Health Information","key":"r41"},{"volume-title":"Treatment guidelines: MUHC Antimicrobial Stewardship Program","year":"2022","author":"McGill University Health Centre Antimicrobial Stewardship Program","key":"r42"},{"issue":"8","key":"r43","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/ajhp\/zxaa419","volume":"78","author":"Kubin CJ","year":"2021","journal-title":"Am J Heal Pharm"},{"issue":"1","key":"r44","doi-asserted-by":"crossref","first-page":"S188","DOI":"10.1093\/ofid\/ofab466.356","volume":"8","author":"Sivakumar D","year":"2021","journal-title":"Open Forum Infect Dis."},{"issue":"1","key":"r45","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1756-5391.2012.01166.x","volume":"5","author":"Zhang L","year":"2012","journal-title":"J Evid Based Med"}],"container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/utppublishing.com\/doi\/pdf\/10.3138\/jammi-2024-0017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T13:33:27Z","timestamp":1752240807000},"score":1,"resource":{"primary":{"URL":"https:\/\/utppublishing.com\/doi\/10.3138\/jammi-2024-0017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6,27]]}},"alternative-id":["10.3138\/jammi-2024-0017"],"URL":"https:\/\/doi.org\/10.3138\/jammi-2024-0017","relation":{},"ISSN":["2371-0888"],"issn-type":[{"type":"electronic","value":"2371-0888"}],"subject":[],"published":{"date-parts":[[2025,6,27]]}}}